Levetiracetam Accord

Levetiracetam, the active ingredient in Levetiracetam Accord, is an antiepileptic presented as an oral tablet for oral use. It is prescribed to manage various seizure types in patients with epilepsy, including partial, generalized tonic‑clonic, and myoclonic seizures, and is approved for use in adults and children as determined by a healthcare professional.

GNH USA supplies Levetiracetam Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our distribution network ensures consistent quality and regulatory compliance across EU and global markets.

Levetiracetam is an antiepileptic medication used to control seizures in the central nervous system.

- Partial seizures: reduces the frequency of focal onset seizures, helping improve daily functioning and reduce the risk of seizure‑related injuries. - Generalized tonic‑clonic seizures: helps prevent convulsive episodes, decreasing the likelihood of loss of consciousness and injury during seizures. - Myoclonic seizures: decreases sudden muscle jerks, contributing to better motor control and quality of life for patients with this seizure type.

Levetiracetam may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness - Fatigue - Headache - Nausea

Serious or Rare Side Effects: - Severe allergic reactions (e.g., anaphylaxis, angioedema) - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Mood alterations including depression, suicidal thoughts, or aggressive behavior

When prescribing levetiracetam, clinicians should consider several precautionary measures to ensure safe use.

- Renal impairment: adjust dose according to renal function and monitor levels. - Hepatic dysfunction: evaluate liver function tests before initiation. - Psychiatric symptoms: monitor patients for mood changes, depression, or suicidal ideation. - Pregnancy: risk category unknown; discuss potential benefits and risks with the patient. - Concomitant CNS depressants: may increase sedation; observe for enhanced central effects. - Store at ambient temperature: keep in original packaging, protect from moisture and heat.

Levetiracetam can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: may significantly reduce levetiracetam plasma concentrations. - Phenytoin: can decrease levetiracetam effectiveness. - Phenobarbital: may lower levetiracetam levels, compromising seizure control.

Moderate Interactions (Monitor Closely): - Alcohol: can enhance central nervous system depression. - Other antiepileptic drugs: may require dose adjustments to maintain therapeutic effect. - Renal excretion inhibitors: monitor renal function and consider dosage modification.